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To identify novel cellular genes that could potentially act as predictive molecular markers for human cervical cancer, we
employed RT–PCR differential display, reverse Northern and Northern blot analysis to compare the gene expression proﬁles
between squamous cell carcinoma biopsies and adjacent histo-pathological normal epithelium tissues. Twenty-eight cDNA
clones were isolated that were demonstrated to be consistently over-expressed in squamous cell cervical cancer biopsies of
FIGO stages 1B to 3B. Most importantly, it was observed that, in addition to their over-expression in cancer lesions, some of
these genes are upregulated in the presumably histo-pathological normal adjacent tissues. Of particular interest is clone
G30CC that has been identiﬁed to be the gene that encodes S12 ribosomal protein. When employed for RNA–RNA in situ
hybridization experiments, expression of G30CC could be detected in the immature basal epithelial cells of histo-pathological
normal tissues collected from cervical cancer patients of early FIGO stages. In comparison, the expression of G30CC was not
detected in cervical tissues collected from patients admitted for surgery of non-malignant conditions. These results allow the
distinct possibility of employing the ribosomal protein S12 gene as an early molecular diagnostic identiﬁer for the screening of
human cervical cancer and a potential target employed for cancer gene therapy trials.
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Cancer of the uterine cervix is one of the most frequent malig-
nancies in women worldwide. The 5-year survival rate of
recurrent cervical cancer was only approximately 5% mainly
due to the absence of effective systemic therapy that would
increase the survival of patients with recurrent disease (Burke
et al, 1987; Piamsomboon et al, 1996; Lanciano, 1996). Epide-
miological studies demonstrate that the major risk factor for
the development of pre-invasive cervical intra-epithelial neoplasia
(CIN) or invasive carcinoma of the cervix is related to HPV
infection. It has been proposed that infection with certain
HPV types (mainly types 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 59, and 68) are most likely to progress to cancer
(Herrero et al, 2000). Continuous expression of the HPV onco-
proteins E6, E7 and E5 of the high risk HPV subtypes also
appears to be necessary for maintaining the malignant phenotype
of cervical cancer patients (zur Hausen, 2000). The detection of
infection with the known HPV subtypes associated with high risk
of cervical cancer has therefore been considered as useful
markers for the diagnosis of cervical cancer (Klaes et al, 1999).
However, the malignant transformation of cervical epithelial cells
requires a long latency period. It is estimated that the mean
duration of pre-clinical lesions could be up to 16 years (Bos et
al, 1997). It has been suggested that most of the infections with
the known HPV subtypes associated with high risk of cervical
cancer usually last less than a year (Ho et al, 1998). Moreover,
the known HPV subtypes associated with high risk of cervical
cancer can also be found in healthy normal woman without clin-
ical evidence of cervical lesions (Kjaer et al, 1997). Therefore,
determination of the HPV genotypes alone may not be sufﬁcient
in assessing the progression of cancer in uterine cervix.
The vast majority of low-grade CIN lesions regress sponta-
neously, and it has been suggested that approximately 1% of
CIN1 lesion and about 10% of CIN3 lesions actually progress to
cancer (Duggan et al, 1998; Ostor, 1993). Despite the observed
low risk for cancer progression, the current treatment of choice
for all high-grade CIN cervical lesions is still complete excision
of the lesion inclusive of the transformation zone. This is adopted,
in the absence of adequate genetic markers to monitor disease
progression, to securely prevent the development of invasive carci-
nomas. Thus, the lack of suitable cancer progression marker results
in a signiﬁcant number of cervical cancer patients being over-trea-
ted. Therefore, sensitive and objective diagnostic markers that
could assess the potential of the invasiveness of cervical neoplastic
cells detected in cervical cancer patients would be of tremendous
clinical value. Since it has been estimated that over 75% of all
cervical cancer cases reported are squamous cell carcinoma
(Vizcaino et al, 2000), we have therefore employed differential
display as a tool to search for candidate genes with accurate predic-
tive value for squamous cell cervical carcinoma. In the present
manuscript, we have focused to study the gene expression proﬁles
of biopsies collected from patients with squamous cell cervical
carcinoma of different FIGO stages (FIGO News, 1987) in compar-
ison to the adjacent histo-pathological normal epithelium.
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Tissue samples
Surgically resected squamous cell cervical cancer biopsies and the
corresponding carcinoma adjacent histo-phenotypical normal
epithelium were obtained from 34 patients with informed consent.
Punch biopsies with tischler forceps were taken from the tumour
lesion for histopathological assessment as well as for RNA analysis.
For histopathological analysis, the tissues were ﬁxed in 10% neutral
buffered formalin and processed into parafﬁn blocks. Multiple step
sections were made and stained with haematoxylin and eosin.
Where indicated, PAS with and without diastase digestion and
mucicarmine stains were performed. The tissues collected for mole-
cular analyses were snapped frozen and stored in liquid nitrogen.
Normal cervical tissue biopsies collected from four non-cervical
cancer patients, with informed consent, were also included in this
study. The histology of the presumably normal epithelial tissues
collected adjacent to the carcinoma were further ascertained to
be normal by pathologists. The staging of the cervical cancer was
performed according to the principle recommended by the Interna-
tional Federation of Obstetrics and Gynaecology (FIGO) (FIGO
News, 1987).
Differential display and gene fragments cloning
Total RNA was puriﬁed from the cervical cancer biopsies using
TRIZOL Reagent (Life Technologies, Grand Island, NY, USA). After
treatment with RNase-free DNase I (Promega, Madison, WI, USA),
1 mg of total RNAs were reverse transcribed with the primer P21
(3'-GTTTTTTTTTTTCGAA-5'). The reverse transcribed cDNA were
then ampliﬁed by PCR in the presence of 1 mCi [a-
33P]dATP (New
England Nuclear, Boston, MA, USA) and either primer P30 (5'-
AAGCTTGGTGACA-3'), P31 (5'-AAGCTTAGTCAAG-3'), or P32
(5'-AAGCTTCCACAGC-3'). The PCR cycling parameters were
948C for 30 s, 408C for 2 min, and 728C for 30 s for a total of 40
cycles and followed by one single step at 728C for 10 min. The
PCR products were then separated on Gel-Mix 6 polyacrylamide
gel (Life Technologies, Grand Island, NY, USA). Bands that were
differentially expressed were excised and the cDNA fragments eluted
by boiling the gel pieces in 100 mlH 2O for 15 min. These cDNA frag-
ments were subsequently employed as templates for PCR re-
ampliﬁcation using similar conditions as described above. Re-ampli-
ﬁed cDNA fragments were then cloned into either the pCR2.1 vector
via the TA cloning system from Invitrogen (San Diego, CA, USA), or
cloned into the pCR-TRAP vector system from GenHunter (Nash-
ville, TN, USA).
Reverse Northern blot
DNA (2 mg) of the ampliﬁed gene fragment of each of the puriﬁed
clones, along with various amounts of a-actin DNA (0.5, 1, 2, or
4 mg) were blotted on Hybond-N
+ nylon transfer membrane
(Amersham, Piscataway, NJ, USA) using the slot-blot apparatus.
The spotted DNA were denatured for 5 min at room temperature
with 1.5 M NaCl, 0.5 M NaOH, and neutralized for 5 min at room
temperature with 1.5 M NaCl, 1 M Tris-HCl pH 7.4, the membrane
was then incubated at 808C for 2 h to ﬁx the DNA. The
32P-
labelled cDNA probes were prepared by reverse transcription of
30 mg of total RNA isolated either from the pooled tumour biop-
sies of six patients or from their matched normal biopsies using
1000 U of SuperScript
TMII reverse transcriptase (Life Technologies,
Grand Island, NY, USA) in the presence of 60 mCi [a-
32P]dATP
and [a-
32P]dCTP (NEN, Boston, MA, USA). RNAs were hydro-
lyzed by incubation for 30 min at 658C with 9 ml 3 N NaOH in
70 ml-reaction volume. Neutralization of the reaction mixture was
performed by the addition of 30 ml1M Tris-HCl (pH 7.4), 9 ml
2 N HCl and 22 mlH 2O. Hybridization was subsequently
performed at 408C. The net fold increase was calculated as the ratio
of gene expression obtained with the probe derived from RNA of
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Figure 1 Differential display analysis. Puriﬁed total RNA from cervical cancer biopsies was reversed transcribed with the primer P21 (see Materials and
Methods). The reverse transcribed cDNA were then ampliﬁed by PCR in the presence of 1 mCi [a-
33P]dATP and either primer P30, P31, or P32. The PCR
products were then separated on polyacrylamide gel. (A) RT–PCR differential display with the primer pair P21/P30. (B) RT–PCR differential display with
the primer pair P21/P31. (C) RT–PCR differential display with the primer pair P21/P32. Seventeen bands selected following differential display analyses with
the corresponding primer pairs, as indicated in the ﬁgure, were employed for subsequent cloning.
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(2), 274–281cancerous tissue over the level of gene expression obtained from
the RNA of normal tissues following normalization of the RNA
employed with a-actin.
Northern blot analysis
Twenty micrograms of total RNA were electrophoresed and trans-
ferred to Hybond-N
+ nylon membrane (Amersham, Piscataway,
NJ, USA). Cloned gene fragments were labelled using high prime
DNA labelling kit (Boehringer Mannheim GmbH, Mannheim,
Germany) and employed as hybridization probe. Hybridization
and washes were performed essentially as described previously
(Soong and Hui, 1992). The signal obtained following hybridiza-
tion to the house keeping gene G3PDH cDNA probe was
employed as an internal reference to standardize the amount of
RNA. The signal of hybridization obtained were analyzed and
quantitated by densitometric scanning with the BioRad FX Phos-
phorImager (BioRad, Richmond, CA, USA).
RNA–RNA in situ hybridization
The RNA–RNA in situ hybridization was performed by DIG
(digoxigenin)-labelled cRNA probe using the DIG RNA labelling
Kit from Boehringer Mannheim (Boehringer Mannheim GmbH,
Mannheim, Germany). Sub-clones with the gene fragment of inter-
est inserted in opposite orientation were selected to synthesize the
sense and anti-sense hybridization probe. After linearization of the
template DNA at the unique BamHI site, 75 U of T7 RNA poly-
merase and DIG-UTP were added to synthesis the DIG-labelled
transcripts.
Frozen tumour sections (10 mm thick) were sectioned from the
frozen tumour biopsies and were mounted directly onto the micro-
scope slides. The sections were ﬁxed in PBS containing 4%
paraformaldehyde by ﬁrstly incubating at 508C for 2 min and then
for 5 min at room temperature. Pre-hybridization was performed by
incubating the sections at 378C for 1 h in block solution containing
5% skim milk powder, 46 SSPE, 50% deionized formamide, 30 mg
herring sperm DNA, 1% SDS and DEPC-treated H2O. DIG-labelled
cRNA probe (200 ng ml
–1was added to the tissue section and incu-
bated overnight at 378C in hybridization buffer (16.6% dextran
sulphate, 5% skim milk powder, 46 SSPE, 50% deionized forma-
mide, 1% SDS and DEPC-treated H2O). Following hybridization,
the slides were washed twice with 26 SSC at RT for 5 min. The
tissue sections were then incubated at RT for 2 h with 100 mM
Tris-HCl pH 7.5 and 150 mM NaCl buffer containing 1% BSA
and 0.5% alpha-alkaline phosphatase-conjugated anti-DIG antibody
(BM, MannLein, Germany). The slides were subsequently developed
at RT overnight by soaking in 0.1 M Tris-HCl pH 9.5, 0.1 M NaCl,
0.05 M MgCl2, 3.4% NBT, 1.8% BCIP, 2.4% levamisole in the dark.
The colour reaction was stopped by transferring the slides to 10 mM
Tris-HCl pH 8 and 1 mM EDTA at RT for 5 min and soaked in
H2O for 5 min at RT. Following counter-staining in Haematoxylin
(BDH Laboratory Supplies, Dorset, UK) for 2–5 s, the slides were
ﬁnally washed with H2O at RT and mounted with coverslips in
Kaiser’s glycerol gelatin solution (Merk KgaA, Darmstadt,
Germany). Slides were analyzed using the Olympus BX 60 micro-
scope (Olympus Optical Co. Ltd).
RESULTS
Identiﬁcation of cDNA fragments speciﬁcally
over-expressed in human cervical cancer biopsies by
differential display
Differential display is a PCR-based method that allows the simul-
taneously comparison of mRNAs from closely related cell
populations (Liang and Pardee, 1992; Liang et al, 1993, 1994). In
this study, we have produced ﬁngerprints of cDNA fragments using
mRNAs puriﬁed from biopsies of human squamous cell cervical
carcinoma and compared these with the corresponding cDNA
ﬁngerprints generated from mRNAs of matched histological
normal epithelium tissues.
One microgram of total RNA extracted from each cervical
biopsy was reverse transcribed using the P21 primer. This was
followed by a subsequent PCR ampliﬁcation step employing the
P21/P30, P21/P31, or P21/P32 PCR primer pairs. All PCR reac-
tions, including the RT step, were performed in triplicates to
ensure reproducibility. In addition, each of the PCR products
was analyzed in different electrophoretic separations employing
denaturing polyacrylamide gels with various running times. The
gel patterns of the ampliﬁed PCR products of six independent
mRNAs puriﬁed from different cancer biopsies and matched
normal tissues gave virtually identical gel patterns for each of the
PCR primer set employed (Figure 1). Bands that were differentially
expressed were excised and the cDNA fragments puriﬁed as
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Figure 2 Reverse Northern blot. DNA (2 mg) of the ampliﬁed gene
fragment of each of the puriﬁed clones, along with various amount of a-ac-
tin DNA (0.5, 1, 2, or 4 mg) were blotted on Hybond-N
+ nylon transfer
membrane using the slot-blot apparatus. After denaturation, neutralization
and DNA ﬁxation, the ﬁlters containing the spotted DNA were hybridized
to
32P-labelled cDNA probes. (A) Autoradiogram obtained after Reverse
Northern blot hybridization of the spotted cloned gene fragments to a
probe prepared by reverse transcription of 30 mg of total RNA puriﬁed
from the pooled tumour biopsies of six cervical cancer patients. (B) Auto-
radiogram obtained after Reverse Northern blot hybridization of the
spotted cloned gene fragments to a probe prepared by reverse transcrip-
tion of 30 mg of total RNA puriﬁed from the corresponding pooled normal
tissue biopsies of the same six cervical cancer employed in (A). (C) The
identity and orientation of the cloned gene fragments as spotted on the ﬁl-
ter membranes.
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British Journal of Cancer (2002) 86(2), 274–281 ã 2002 The Cancer Research Campaigndescribed in Materials and Methods. These cDNA fragments were
subsequently employed as templates for PCR re-ampliﬁcation using
conditions as described in Materials and Methods. Re-ampliﬁed
cDNA fragments were then cloned into either pCR2.1 pCR-TRAP.
Twenty-eight cDNA clones which level of expression were subse-
quently conﬁrmed by Reverse Northern analysis to be
signiﬁcantly increased in the cervical cancer biopsies in comparison
to their matched histological normal tissues with the net folds of
increase ranging from 1.7 to 4.3 (Figure 2).
Through the BLASTn sequence search (National Centre for
Biotechnology Information), most of the clones identiﬁed are either
homologous to previously reported genes in the Genbank or are
known expressed sequence tags (EST) (Table 1). The DNA sequences
ofclonesG30CC,G30CD,G30CI,G30CJ,G31C5H,G32C3B,G32C4B
andG32C7arelocatedwithinthecodingregionsofthereportedgenes,
while the DNA sequences of clones G31C4B and G32C2C are in the
reverse orientation with respect to thatof the reported gene sequences
in the Genbank. The DNA sequences for clones G30CB and G31C6B
were also found to be in the reverse orientation with reference to the
sequences of two reported EST clones. Eleven of the 28 clones, viz.
G30CE, G30CK, G31C4C, G31C5B, G31C5C, G31C5D, G31C5G,
G32C2A, G32C3C, G32C4D and G32C5A appear to be novel gene
sequences as they do not match to any of the reported gene sequence
in the GenBank or EST databases (Table 1).
Expression of the cloned cDNA fragments in various FIGO
stages of human cervical cancer
To determine if the level of gene expression of some of the cloned
genes correlate with the tumorigenicity of human squamous cell
cervical cancer, Northern blot analyses were performed. mRNA
from cervical cancer biopsies of FIGO stages 1B (four patients),
2A (three patients), 2B (two patients), and 3B (four patients),
along with their matched normal tissue biopsies were isolated.
The level of expression of the cloned genes identiﬁed in this study
in cervical cancer biopsies of various FIGO stages was compared to
that of their matched normal tissues. Our results demonstrated that
expression of clone G30CC was consistently upregulated in the
cervical cancer tissue biopsies examined (Figure 3). Cervical cancer
biopsies obtained from stage 2A patients gave the highest level of
expression of G30CC (Figure 3). DNA sequence homology analyses
suggested that clone G30CC is homologous to the human riboso-
mal protein S12 mRNA (Table 1).
Similarly, DNA sequence homology analyses suggested that
clones G30CA and G32C4B are of mitochondrial origin with clone
G32C4B encodes the mitochondrial subunit NADH dehydrogenase
4, and clone G30CA is homologous to the human 16S ribosomal
RNA that is required for the translation of mitochondrial subunits
(Table 1). The expression of these two genes was greatly upregu-
lated when early stages (1B and 2A) squamous cell cervical
cancer biopsies were examined (Figure 3). Expression of clone
G32C4B was increased by up to six-fold in stage 1B cervical cancer
biopsies in comparison to the corresponding adjacent normal
tissues (Figure 3).
One of the novel genes identiﬁed in this study, clone G31C5G,
has been demonstrated to be speciﬁcally upregulated in stages 1B
and 2A human squamous cervical carcinoma (Figure 3). It was
found that the level of expression of both clone G30CI (human
guanine nucleotide binding protein b5) and clone G32C2B (human
general transcription factor IIB) were greatly upregulated in stage
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Table 1 Cloned cDNA fragments and their Reverse Northern blot analysis
Size of Fold ampliﬁed Localization Identities
Clone cDNA (bp) in cancer tissue Homology in GeneBank database/human EST (Accession number) Localization (%)
G30CA 204 2.08 Human 16S ribsomal RNA (6137796) Mitochondrial DNA 99
G30CB 207 2.64 Human s1 soares foetal liver spleen 1NFLS (human EST: H72762)
a –9 7
G30CC 204 1.94 Human ribosomal protein S12 (RPS12) mRNA (NM_001016) 6q 99
G30CD 207 3.00 Human mRNA for collagenase (X05231) 11q22.3 99
G30CE 206 4.27 No match ––
G30CH 202 3.55 Human ZNF01 and HUMORFKG1B genes (AF205588) 10 98
G30CI 207 2.13 Human guanine nucleotide binding protein b5 (GNB5) mRNA (NM_006578) 15 100
G30CK 206 1.68 No match ––
G31C4B 258 1.67 Homo sapiens chromosome 1 clone RP4-758N20 (AL03705)
a 1p31.3–p32.2 95
G31C4C 254 1.65 No match ––
G31C5B 183 3.29 No match ––
G31C5C 183 1.65 No match ––
G31C5D 176 2.31 No match ––
G31C5E 179 3.57 Human capping protein muscle Z-line, a1 mRNA (NM_003832) 7q31.2–q31.3 1.00
G31C5G 179 4.25 No match ––
G31C6A 242 2.58 (a) human L-3-phosphoserine-phosphatase homo (CO9) mRNA (NM_003832) 7q11.2 99
(b) PA9=candidate tumour suppressor gene {3' region} (S82076) 97
G31C6B 243 2.33 (a) Soares foetal liver spleen INFLS S1 human cDNA (human EST: W93382)
a –9 8
(b) Prostate gland I Homo sapiens cDNA 3' end (human EST: AA370225)
a 98
G32C2A 312 1.78 No match ––
G32C2B 311 2.44 Human general transcription factor IIB (GTF2B) mRNA (NM_001514) 1p22–p21 98
G32C2C 297 1.56 Human clone 3A ETS-like protein mRNA (U30172)
a –9 6
G32C3A 307 2.00 (a) Human cDNA FLJ10841 ﬁs, clone NT2RP4001339 (AK001703) – 98
(b) Human NY-REN-45 antigen mRNA (AF155110) 97
G32C3B 310 1.74 Human NADH dehydrogenase subunit 6 (6137796) Mitochondrial DNA 95
G32C3C 303 2.97 No match ––
G32C4B 260 3.94 Human NADH dehydrogenase subunit 4 (6137796) Mitochondrial DNA 100
G32C4D 264 1.58 No match ––
G32C5A 257 1.62 No match ––
G32C6 250 1.93 (a) Human ubiquitin speciﬁc protease 3 (USP3) mRNA 15q22.3 100
(b) Human SIH003 mRNA (AF077040) 100
G32C7 224 2.23 Human procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), 10q21.3–q23.1 100
alpha polypeptide 1 (P4HA1) mRNA
aThe reported sequence in the EST/GeneBank database is in the reverse orientation with respect to our cDNA fragment.
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(2), 274–2811B squamous cell cervical cancer. In addition, the expression of
clone G32C2B was also upregulated in stage 2A cervical cancer
biopsies (Figure 2). Two hybridized bands (2.4 and 1.8 kb) could
be observed when clone G31C5E was employed as the hybridiza-
tion probe in our Northern blot analysis. When DNA sequence
homology analyses were performed, the best matched in the
homology search to clone G31C5E in the GenBank DNA sequences
was the human capping protein muscle Z-line a1 mRNA which is
of 2.4 kb. If clone G31C5E is indeed the human capping protein
muscle Z-line a1gene, the nature of the 1.8 kb gene product
detected in our Northern blot study is presently unknown.
More importantly, through the Northern blot analyses, we
demonstrated that the expression of these seven cloned genes iden-
tiﬁed were also elevated in the matched histological normal tissue
biopsies collected together with the different FIGO stages of the
squamous cervical cancer biopsies (Figure 3). To explore the
potential clinical signiﬁcance of the upregulation of these genes
in the histologically normal cervical tissues adjacent to the tumour
proper and to identify the cell types that expressed the gene
product in question, one of the clones, clone G30CC, was
employed for RNA-RNA in situ hybridization study. Both the
anti-sense and sense orientations of clone G30CC were synthesized
as described in the Materials and Methods and employed as probes
for in situ hybridization studies. The sense probe was employed as
a negative internal control for the in situ hybridization.
In situ hybridization studies were performed using frozen
sections of squamous cell cervical cancer biopsies of various FIGO
stages and their matched histological normal tissues. A total of 14
patients of different FIGO stages were analyzed by in situ hybridi-
zation and the results of a representative patient were shown
(Figure 4). The histology identiﬁcations were performed on conse-
cutive tissue sections following H&E staining. When the normal
tissue sections were examined, the basement membrane is intact
and the immature epithelial cells were of uniform size and are
conﬁned to the basal-layer (Figure 4). The mature cells were
normally found in the para-layers (Figure 4). On the other hand,
in the case of carcinomas, cellular and nuclear variations of differ-
ent sizes and shapes could be observed (Figure 4).
For in situ hybridization studies with clone G30CC as probe,
positive signals were mainly observed in the cytoplasm (Figure
4). Expression of clone G30CC was consistently detected in cervical
carcinomas of FIGO stages 1B, 2A, 2B and 3B (Figure 4). Although
the G30CC anti-sense probe did not hybridize to the para-epithelial
cell layers of matched normal tissues obtained from FIGO stages 1B
and 2A cervical cancer patients, speciﬁc hybridization could be
detected within the immature basal epithelial cell layers (Figure
4). More signiﬁcantly, when the matched normal tissues obtained
from FIGO stages 2B and 3B cervical cancer patients were studied
with the G30CC anti-sense probes, strong hybridization signals
could be obtained in the immature epithelial cells of histological
normal tissue sections (Figure 4). Conversely, G30CC expression
could not be detected when normal tissue sections collected from
non-cervical cancer patients were tested (Figure 5).
DISCUSSION
To identify tumour-speciﬁc molecular alterations in human squa-
mous cervical cancer, we have employed differential display and
cDNA gene cloning to compare the global gene expression
proﬁles of six tissue biopsies of cervical cancer patients of differ-
ent FIGO stages with their corresponding matched normal tissue
biopsies (Figure 1). We had chosen to utilize biopsies obtained
from cervical cancer patients of different FIGO for our differential
display studies. This is to avoid the generation of bias against
isolating ‘false positive’ differentially displayed cDNAs fragments
from a speciﬁc type of tumour biopsy (Liang et al, 1993). We
reasoned that true differential displayed bands that are important
for carcinogenesis should be generically up-regulated or down-
regulated in most, if not all, cervical cancer samples when
compared to the adjacent normal tissues and that these bands
should be reproducibly generated by the differential display
analyses. A total of 44 cDNA clones were initially isolated from
the 17 distinct bands obtained following differential display
analyses with the three sets of primers employed. We could
isolate more than one cDNA clone from a single distinctive
differential display band. This is most likely to be attributed to
the co-migration of gene fragments during electrophoretic separa-
tion. All the clones puriﬁed have been veriﬁed to have the
expected PCR primer sequences incorporated at their 5' and 3'
ends by DNA sequencing. The expression of 28 of these 44 cDNA
clones were subsequently conﬁrmed by reverse Northern blot
analysis to be upregulated in human squamous cell cervical cancer
biopsies (Figure 2 and Table 1).
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Net fold increase of the expression in cancer biopsies over
that in matched normal tissue biopsies
FIGO stage 1B 2A 2B 3B
G32C4B 5.88 1.25 0.83 1.37
G30CC 1.37 3.80 2.81 1.17
G30CA 1.83 2.00 0.70 1.72
G31C5G 3.59 3.64 0.93 0.35
G30CI 1.67 0.34 0.47 0.27
G32C2B 1.48 1.51 0.93 0.63
Figure 3 Northern blot analysis employing clones G32C4B, G30CC,
G30Ca, G31C5G, G30CI, G32C2B and G31C5E as probes with total
RNA obtained from human squamous cell cervical carcinoma biopsies of
different FIGO stages and their corresponding adjacent normal tissues.
The summary table shows the folds of increase of the cloned cDNA frag-
ments in the various tumour biopsies in comparison to their matched nor-
mal counterparts after normalization to G3PDH mRNA.
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the levels of expression were upregulated for several different cate-
gories of genes in the corresponding adjacent histopathological
normal tissue biopsies collected from patients with advanced stage
cervical cancer (Figure 3). These include genes for energy
consumption (NADH dehydrogenase 4, G32C4B), translation
(ribosomal protein S12, G30CC; 16S ribosomal RNA, G30CA),
transcriptional regulation (general transcription factor, G32C2B),
signal transduction (guanine nucleotide binding protein b5,
G30CI), and others (G31C5G and G31C5E (Figure 3). It is likely
that as the carcinoma spread, the external adjacent, presumably still
histological normal, tissues are undergoing molecular changes that
are reﬂected in the observed corresponding alterations in their gene
expression.
The strategy adopted in this study to isolate tumour-speciﬁc
genes has certain limitations. Throughout our study, relatively large
tissue biopsies were utilized. These tissues intrinsically represent a
vast mixture of cell types (i.e. stroma, neovascularized endothe-
lium, epithelial nest and inﬂammatory cells). It would be
impossible to rule out some of these biological differences in the
tumour biopsies to that of their normal counterpart. In addition,
there may be inherent differences between the adjacent squamous
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Figure 4 Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding
adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the
DIG RNA labelling Kit from Boehringer Mannheim. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synth-
esis of the sense and anti-sense hybridization probes. Frozen tumour sections (10 mm thick) were sectioned from the frozen tumour biopsies and reacted
with the DIG-labelled cRNA probe. After hybridization and washing, the slides were analyzed using the Olympus BX 60 microscope. The histology identi-
ﬁcations were performed on consecutive tissue sections following H&E staining. The magniﬁcation shown was 6006.
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Although every precaution had been taken to collect the corre-
sponding normal tissues, in some cases, there might be traces of
contaminating tumour tissues especially in some of the advanced
cervical cancer cases studied. The results reported in this study,
therefore, may most likely to reﬂect the importance of the cervical
microenvironment. To clarify these issues, we have performed
RNA-RNA in situ hybridization using G30CC as a representative
hybridization probe.
Results of our RNA-RNA in situ hybridization analyses indicated
that G30CC was consistently over-expressed in cervical cancer
biopsies collected from patients of FIGO stages 1B to 3B diseases
(Figure 4). It was also observed that the expression of clone
G30CC was signiﬁcantly increased in the corresponding adjacent
histological normal biopsies obtained from cervical cancer patients
having stage 2B and 3B diseases (Figure 4). The expression of
G30CC was also upregulated within the immature epithelial cells
in tissue sections of biopsies collected from early stage (1B and
2A) cervical cancer patients (Figure 4). It is therefore most likely
that the expression of G30CC has been molecularly modiﬁed in
the phenotypically normal cervical epithelium tissues adjacent to
carcinoma.
DNA sequence homology analyses showed that clone G30CC is
homologous to the human ribosomal protein S12 mRNA (Table
1). The over-expression of certain ribosomal protein mRNA has
been reported to correlate with tumorigenicity (Chanseob et al,
1998; Henry et al, 1993; Kumar et al, 1999). The function of certain
ribosomal proteins has also been implicated in the regulatory
processes that may be important in carcinogenesis (Erikson and
Maller, 1989; Ziemiecki et al, 1990). The over-expression of riboso-
mal protein has also been suggested to be an early event in the
neoplastic progression to malignancy (Pogue-Geile et al, 1991).
The expression of ribosomal protein S12 gene had been reported
to increase in adenomatous polyps when compared to normal
mucosa (Pogue-Geile et al, 1991). These observations are consistent
with our results that the expression of G30CC was upregulated for
cervical cancer biopsies collected from patients of early FIGO stages
(Figure 3B) and suggests the possibly concomitant increase expres-
sion of clone G30CC with the onset of cervical neoplasia.
Events such as genetics mutations and alterations in the regula-
tion of signal transduction pathways play important roles in the
initiation of cancer (Hartwell and Kastan, 1994; Weinberg,
1996). During the progression of cancer, the local microenviron-
ment has been demonstrated to contribute signiﬁcantly for the
growth of tumour (Tlsty and Hein, 2001). The local microenvir-
onment can inﬂuence the growth of tumours via the continuous
enhancement of proliferation through a paracrine mechanism
(Tlsty and Hein, 2001). Neoplastic epithelial cell could produce
mitogenic factors such as IGF (insulin-like growth factor) and
KGF (keratinocyte growth factor) to activate ﬁbroblasts (Basset
et al, 1990; Chiquet-Ehrismann et al, 1986; Ronnov-Jessen et al,
1996; Singer et al, 1995; Wright et al, 1994). These factors may
in turn promote the proliferation of neoplastic epithelial cells
either by the modulation of extracellular matrix or the release
of bound growth factors (Basset et al, 1990; Chiquet-Ehrismann
et al, 1986; Ronnov-Jessen et al, 1996; Singer et al, 1995; Wright
et al, 1994). In this context, puriﬁed carcinoma-associated ﬁbro-
blast cells have been shown to exhibit an alteration in the
expression of growth factors (Ellis et al, 1994; Frazier and Groten-
dorst, 1997; Nakamura et al, 1997; Yan et al, 1993; Yee et al,
1991). Changes in stromal cells have also been postulated to
enhance the tumorigenic phenotypes of epithelial cells (Olumi et
al, 1999; Rinehart and Torti, 1997; Skobe and Fusenig, 1998). This
activated stromal microenvironment may affect the proﬁle of gene
expression of the adjacent epithelial cells. This hypothesis is
supported by our current results demonstrated that certain genes,
such as the ribosomal protein S12 gene, is upregulated in the
adjacent tissues of progressive cancers.
The presence of integrated HPV DNA is detected in over 90% of
cervical carcinoma (Bosch et al, 1995). Moreover, HPV16 DNA, a
high-risk HPV subtype for cervical cancer, can be found in more
than half of cervical cancers (Ronco et al, 1998). Integration of
the HPV genome, in most cases, results in the expression of the
viral oncogenes E6 and E7 and the co-transcribed cellular
sequences (Klaes et al, 1999). It was clearly demonstrated that
the expression of these oncogenes is essential for the induction
and maintenance of the neoplastic phenotype of cervical cancer
cells (zur Hausen, 2000). Conceivably, the activated microenviron-
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Figure 5 Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ
hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense
hybridization probes. The magniﬁcation shown was 6006.
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British Journal of Cancer (2002) 86(2), 274–281 ã 2002 The Cancer Research Campaignment induced by the adjacent cervical cancer cells might facilitate
the expression of the integrated HPV viral oncogenes and enable
the existing phenotypical normal cells to be more prone for clonal
outgrowth into cancer cells. The next obvious objective is to eval-
uate the possible role of the ribosomal protein S12 gene in pre-
invasive cervical cancer.
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